<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04761315</url>
  </required_header>
  <id_info>
    <org_study_id>TFM 2016-18</org_study_id>
    <nct_id>NCT04761315</nct_id>
  </id_info>
  <brief_title>Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)</brief_title>
  <official_title>Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The presence of interatrial block (IAB) is associated with the development of atrial&#xD;
      fibrillation (AF). The aim of this study was to determine whether P-wave duration and&#xD;
      presence of IAB before the implantation of a cardiac implantable electronic device (CIED) are&#xD;
      associated with the presence of atrial high rate episodes (AHRE), during long-term follow-up.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The presence of interatrial block (IAB) is associated with the development of atrial&#xD;
      fibrillation (AF). The aim of this study was to determine whether P-wave duration and&#xD;
      presence of IAB before the implantation of a cardiac implantable electronic device (CIED) are&#xD;
      associated with the presence of atrial high rate episodes (AHRE), during long-term follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Atrial high rate new episodes</measure>
    <time_frame>24 months</time_frame>
    <description>New episodes of atrial high rate episodes</description>
  </primary_outcome>
  <enrollment type="Actual">380</enrollment>
  <condition>Fibrillation, Atrial</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in sinus rhythm, with or without previous paroxysmal AF and with dual-chamber&#xD;
        pacemakers (PMs), implantable cardioverterdefibrillators (ICDs), and devices for cardiac&#xD;
        resynchronization therapy (CRT) capable of atrial activity monitoring were included in the&#xD;
        study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients in sinus rhythm&#xD;
&#xD;
          -  with or without previous paroxysmal AF&#xD;
&#xD;
          -  with dual-chamber pacemakers (PMs), implantable cardioverterdefibrillators (ICDs), and&#xD;
             devices for cardiac resynchronization therapy (CRT)&#xD;
&#xD;
          -  capable of atrial activity monitoring were included in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -Previous documented atrial fibrillation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 11, 2020</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardiac implantable electronic devices</keyword>
  <keyword>interatrial block</keyword>
  <keyword>P-wave duration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Embolic Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

